期刊文献+

O型口蹄疫病毒单克隆抗体的制备和鉴定 被引量:3

Preparation and characterization of monoclonal antibody against Foot-and-mouth disease virus serotype O
下载PDF
导出
摘要 利用O型口蹄疫病毒(FMDV)免疫BALB/c小鼠,取其脾细胞与Sp2/0细胞进行融合,经间接ELISA方法筛选和7次亚克隆后获得2株能稳定分泌单克隆抗体(McAb)的杂交瘤细胞株。经间接ELISA检测,2株杂交瘤细胞株(3E1、7E6)的腹水效价分别为1∶25600、1∶102400。间接免疫荧光试验和特异性试验表明2株McAb可与不同株的O型FMDV反应,而不与其他血清型的FMDV反应。Western blot和叠加试验表明2株单抗可识别O型FMDV结构蛋白VP1上的同一个抗原表位。此特异性McAb的获得将为O型FMDV疫苗的研制和诊断方法的建立奠定基础。 The myeloma cells Sp2/0 were fused with the spleen cells from a BALB/c mice immunized with the FMDV type O (LD50=10^-8.5). The positive hybridomas clones (3El, 7E6) were obtained after screening by indirect ELISA. The McAbs had a ascites titer of 1:25 600 and 1:102 400, respectively as detected by indirect ELISA. Both McAbs could react with other strains type O FMDV by indirect immunofluorescence assay (IFA). Western blot and competitive binding assay showed that these McAbs could recognize the same epitope of VP1 protein of FMDV.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2009年第4期325-328,共4页 Chinese Journal of Preventive Veterinary Medicine
基金 国家科技支撑计划(2006BAD06A14 2006BAD06A10)
关键词 O型口蹄疫病毒 单克隆抗体 间接ELISA FMDV serotype O McAb indirect ELISA
  • 相关文献

参考文献8

  • 1Logan D, Abu-Ghazaleh R, Blakemore W, et al. Structure of a major immunogenic site on foot-and-mouth disease virus [J]. Nature, 1993, 362(6420): 566-568.
  • 2Domingo E, Escamis C, Baranowski E, et al. Evolution of foot- and-mouth disease virus [J]. Virus Rese, 2003, 91(1): 47-63.
  • 3萨姆布鲁克 J,拉塞尔 D W.分子克隆实验指南[M].3版.黄培堂,王嘉玺,朱厚础,等译.北京:科学出版社,2002:96—99;1232—1236.
  • 4Tesar M, Berger H G, Marquardt O. Serological probes for some foot-and-mouth disease virus nonstmctural proteins [J]. Virus Genes, 1989, 3: 29-44.
  • 5Crowther J R, Fairs S, Carpenter Q C, et al. Identification of a fifth neutralization site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants [J]. J Gen Virol, 1993, 74: 1547-1553.
  • 6Wang J H, Liang C M, Peng J M, et al. Induction of immunity in swine by purified recombinant VPI of foot-and-mouth disease virus [J]. Vaccine, 2003, 21 (25-26): 3721-3729.
  • 7Jackson T, Sharma A, Ghazaleh R A, et al. Arginine-glycineaspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha (V) beta 3 in vitro [J]. J Virol, 1997, 71: 8357-8361.
  • 8Mason P W, Peider E, Baxt B. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed be an antibody-dependent enhancement pathway [J]. Proc Natl Acad Sci USA, 1994, 91: 1932-1936.

共引文献135

同被引文献49

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部